Jill Cottel, MD - Vitamin D and Autoimmune Disease: A Systematic Review of the Literature (2017 Conference) (LDN, low dose naltrexone)

Angus Dalgleish, MD - The Role of Non-Cytotoxic Drugs in the Management of Cancer (2017 Conference) (LDN, low dose naltrexone)

Beth Livengood, ND - Rheumatoid Arthritis Case Study (2017 Conference) (LDN, low dose naltrexone)

Etiology of rheumatoid arthritis (RA) is autoimmune; has an inflammatory component including food sensitivities. Low Vitamin D a component, as in many diseases. LDN in two cases of RA.

Brian Udell, MD - Review of Recent Statistics for Patients Taking LDN in a Special Needs Pediatric Practice (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Sunday Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Saturday Afternoon Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Saturday Morning Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Friday Afternoon Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Friday Morning Q&A (2017 Conference) (LDN, low dose naltrexone)

Paul Anderson, NMD - Immune Therapies for Multiple Sclerosis (2017 Conference) (LDN, low dose naltrexone)

How LDN can be so successful in treating Multiple Sclerosis (MS) by boosting the immune system and improving the overall wellbeing of the patient.